Marathon Trading Investment Management LLC Pyxis Oncology, Inc. Transaction History

Marathon Trading Investment Management LLC

$201 Million
Q3 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 12, 2024	SELL	$3.06 - $5.58 $124,297 - $226,659	-40,620 Reduced 71.26%	16,380 $54,000
Q1 2024 May 10, 2024	BUY	$2.03 - $6.59 $115,709 - $375,630	57,000 New	57,000 $242,000

Others Institutions Holding PYXS

# of Institutions

101

Shares Held

28.2M

Call Options Held

539K

Put Options Held

54.1K

Deep Track Capital, LP Greenwich, CT

4.18M
Shares

$7.07 Million
0.57% of portfolio
Laurion Capital Management LP New York, NY

3.63M
Shares

$6.13 Million
0.18% of portfolio
Black Rock Inc. New York, NY

2.79M
Shares

$4.71 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.43M
Shares

$4.11 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

1.91M
Shares

$3.22 Million
0.0% of portfolio

View Full List

About Pyxis Oncology, Inc.

Ticker PYXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,096,400
Market Cap $59.3M
Description
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...

More about PYXS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marathon Trading Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marathon Trading Investment Management LLC with notifications on news.

Account